Not admitted · Commitment (own venture)
Rules 1.1.0 · as of 14 Sep 2026
Rick Doblin · Said 6 Dec 2017 · doblin-0060
Quote
Commitment (own venture)
“Based on the current timeline, the first Phase 3 study is expected to be initiated in the first half of 2018 in the U.S., Canada, and Israel. We anticipate submitting our New Drug Application to the FDA in 2021.”
Projections for FY2017-18 in the annual financial report written by Doblin.
The forecaster's own organization can make the outcome happen by its own decision: clinic openings, product launches, hires, trial starts, filings by their own company. Listed in the commitments table, never scored.